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Abstract
In the south of France, Leishmania infantum is responsible for numerous cases of canine
leishmaniasis (CanL), sporadic cases of human visceral leishmaniasis (VL) and rare cases
of cutaneous and muco-cutaneous leishmaniasis (CL and MCL, respectively). Several
endemic areas have been clearly identified in the south of France including the Pyrénées-
Orientales, Cévennes (CE), Provence (P), Alpes-Maritimes (AM) and Corsica (CO). Within
these endemic areas, the two cities of Nice (AM) and Marseille (P), which are located 150
km apart, and their surroundings, concentrate the greatest number of French autochtho-
nous leishmaniasis cases. In this study, 270 L. infantum isolates from an extended time
period (1978–2011) from four endemic areas, AM, P, CE and CO, were assessed using
Multi-Locus Microsatellite Typing (MLMT). MLMT revealed a total of 121 different genotypes
with 91 unique genotypes and 30 repeated genotypes. Substantial genetic diversity was
found with a strong genetic differentiation between the Leishmania populations from AM
and P. However, exchanges were observed between these two endemic areas in which it
seems that strains spread from AM to P. The genetic differentiations in these areas suggest
strong epidemiological structuring. A model-based analysis using STRUCTURE revealed
two main populations: population A (consisting of samples primarily from the P and AM
endemic areas with MON-1 and non-MON-1 strains) and population B consisting of only
MON-1 strains essentially from the AM endemic area. For four patients, we observed sev-
eral isolates from different biological samples which provided insight into disease relapse
and re-infection. These findings shed light on the transmission dynamics of parasites in
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humans. However, further data are required to confirm this hypothesis based on a limited
sample set. This study represents the most extensive population analysis of L. infantum
strains using MLMT conducted in France.
Author Summary
In the south of France, the parasite Leishmania infantum is responsible for diseases that
primarily affect dogs but can also impact humans. Several endemic areas have been clearly
identified in the south of France including the Pyrénées-Orientales, Cévennes (CE), Pro-
vence (P), Alpes-Maritimes (AM) and Corsica (CO). In this study, 270 L. infantum isolates
from four endemic areas, AM, P, CE and CO, were assessed using Multi-Locus Microsatel-
lite Typing (MLMT), a tool applied for population genetic studies. MLMT revealed a
strong genetic differentiation between the Leishmania populations from AM and P with
exchanges observed between these two endemic areas. For four patients, the occurrence of
disease relapses and re-infections was examined. These findings shed light on the trans-
mission dynamics of parasites in humans. This study represents the most extensive popu-
lation analysis of L. infantum isolates using MLMT conducted in France.
Introduction
Leishmaniases are a group of diseases caused by obligatory intracellular protozoan parasites of
the genus Leishmania. Among the species of Leishmania, Leishmania infantum is mostly
responsible for canine leishmaniasis (CanL), although it also causes sporadic cases of human
visceral leishmaniasis (VL), and rare cases of cutaneous and muco-cutaneous leishmaniasis
(CL and MCL) throughout the Mediterranean basin [1]. Transmission to humans is caused by
the bite of infected phlebotomine sandflies, and dogs are considered to be the principal domes-
tic reservoir. In France, the parasite is currently only endemic in the south of France, along the
Mediterranean coast, where several foci have been clearly identified: Pyrénées-Orientales,
Cévennes (CE), Provence (P), Alpes-Maritimes (AM) and Corsica (CO) [2]. In the Provence-
Alpes-Côtes d’Azur (PACA) region, which comprises the AM and P endemic areas, transmis-
sion has been reported for 100 years [3,4]. The two cities of Nice and Marseille, which are
located 150 km apart, and their surroundings concentrate the greatest number of French
autochthonous leishmaniasis cases [2,5]. Although the same species of L. infantum (primarily
zymodeme MON-1), the same predominant vector (Phlebotomus perniciosus) and the same
and unique reservoir (dog) are found in both regions, the transmission environment of VL is
heterogeneous in these two foci [5]. Disease transmission in Nice and the surrounding area is
associated with scattered habitation and mixed forest in the foothills [5]. In contrast, around
Marseille, VL transmission is associated with an urban environment [5]. Regarding the main
vector; Phlebotomus pernicious; the population is quite homogeneous and belongs mainly to
the same haplogroup (for 88% pern01) in Provence, France [6]. The isolates of L. infantum
from AM and P endemic foci have been characterized using Multi-Locus Enzyme Electropho-
resis (MLEE), which is the current reference method. However, MLEE based analyses are lim-
ited at the intrinsic level of polymorphisms. Thus, differentiating between isolates in PACA
region is impossible using the MLEE method [7]. Epidemiological studies on L. infantum
require the use of highly discriminative techniques that can differentiate between MON-1
strains. Multi-Locus Microsatellite Typing (MLMT) has been shown to be a powerful tool for
MLMT of Leishmania infantum in Southeastern France
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population genetics and epidemiological studies of Leishmania spp. [8]. This tool has been
already applied to genotype L. infantum isolates from healthy blood donors, sandflies, dogs
and human patients in Southern France [9]. Genetic differentiations were evidenced between
asymptomatic carrier strains and non-asymptomatic carrier strains and especially between
asymptomatic carrier and HIV+ populations [9]. However, due to the weak sample size, these
results must be confirmed on a larger sample set [9].
In the current study, microsatellite markers were used to analyze the genetic diversity of L.
infantum parasites from Southeast France, with a focus on the PACA region. We assessed an
extensive panel of isolates from an extended time period (1978–2011), from the two endemic
regions of AM and P. The geographical and temporal distributions of genotypes were exam-
ined. The microsatellite profiles were used to assess relapse and re-infection among patients as
well as the association between genotype and the various clinical forms of the disease.
Materials and Methods
Parasites
The L. infantum isolates used in this study were obtained from the collection of the Centre
National de Référence des Leishmania (Leishmania collection, BRC-Leish, Montpellier, France,
BioBank N° BB-0033-00052). All human and animal samples had been isolated from patients
and animals as part of routine diagnosis and treatment with no unnecessary invasive proce-
dures. A total of 270 L. infantum isolates from the south of France were included in this study
(Table 1). This panel included 247 human isolates from 239 patients (four patients harbored
more than one isolate), 20 from CanL, one from feline leishmaniasis and two from sandflies.
Among the 239 patients, there were 154 adult VL cases, 58 infant VL cases, 13 CL cases (five
infants, seven adults and one unknown), three MCL adult cases, nine asymptomatic carriers
(in adults) and two unknown cases (one adult and one unknown). Among the 247 human sam-
ples, 139 were isolated from immunocompetent patients, 95 from immunocompromised HIV
+ patients, 11 from immunocompromised patients other than HIV+ (e.g., renal transplanta-
tion, lymphoma, auto immunity disease and cancer) and two from unknown cases. The loca-
tion of isolates based on their position relative to the Vars River (S1 Table) was used for genetic
differentiation analysis.
Concerning the geographical distribution (Fig 1), the samples were collected from the
endemic areas of AM (n = 178), P (n = 75), CO (n = 9) and CE (n = 8). The samples were iso-
lated at the University Hospitals of Nice, Marseille and Montpellier (France) between 1978 and
2011. MLEE typing and cryoconservation were performed at the Centre National de Référence
des Leishmania (Leishmania collection, BRC-Leish, Montpellier, France, BioBank N° BB-0033-
00052). Overall, 259 isolates were characterized as zymodeme MON-1, six were MON-24, one
was MON-11, one was MON-80 and one was MON-108. The data were unavailable for two
isolates. For this study, the primary cultures from the patient stored at -80°C were thawed and
the cells were cultured for six days before harvesting for DNA extraction.
DNA extraction
The microsatellite data indicated with an asterisk in Table 1 were obtained from a previous
study [9].
DNA of the remaining isolates was extracted from promastigotes grown in Schneider’s
insect medium (Sigma Aldrich, France) supplemented with serum calf, urine, penicillin, strep-
tomycin and L-glutamine (Sigma Aldrich). Promastigotes were harvested on the sixth day of
culture, and DNA was extracted from a pellet of 2X108 parasites using a QIAamp DNAmini
kit (Qiagen, France) according to the manufacturer’s instructions. DNA extracted from the
MLMT of Leishmania infantum in Southeastern France
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004303 January 25, 2016 3 / 28
Table 1. Designation and characteristics of Leishmania infantum isolates used in this study.
Endemic
area
Patients Sample WHO code Y C F /
H
HIV
status
Zymo G P Sub-Pop
A
Sub-Pop
A
Sub-Pop
B
K = 6 K = 4 K = 2
P Patient 1 MHOM/FR/94/LPM135 1994 VL HIV MON-1 1 A 6 3
AM Patient 2 MHOM/FR/90/LPN63 1990 VL HIV MON-24 2 A 6 3
AM Patient 3 MHOM/FR/2002/LPN202 2002 IVL MON-1 3 A 4 1
P MCAN/FR/2000/LPM206 2000 CanL MON-1 4 A 4 1
AM Patient 4 MHOM/FR/2003/LPN212 2003 VL HIV MON-1 4 A 4 1
AM Patient 4 MHOM/FR/2004/LPN243 2004 RVL HIV MON-1 4 A 4 1
AM Patient 5 MHOM/FR/90/LPN67 1990 VL HIV MON-1 5 A 4 1
AM Patient 6 MHOM/FR/96/LPN126 1996 IVL MON-1 6 A 4/3 1
P Patient 7 MHOM/FR/93/LPM110 1993 VL HIV MON-11 7 A 4/6 1/3
AM Patient 8 MHOM/FR/90/LPN62 1990 VL MON-1 8 B 1
AM Patient 9 MHOM/FR/98/LPN163 1998 IVL MON-1 9 B 1
P Patient 10 MHOM/FR/96/LPM150 1996 VL HIV MON-1 10 A 4/5 1/2
AM Patient 11 MHOM/FR/2001/LPN192 2001 IVL MON-1 11 B/
A
CE MCAN/FR/2006/LPN278 2006 CanL MON-1 12 A 4/5 1/2
P Patient 12 MHOM/FR/97/LPM180 1997 VL HIV MON-1 13 A 5 2
P MCAN/FR/2000/LPM207 2000 CanL MON-1 13 A 5 2
P Patient 13 MHOM/FR/2009/LPM262 2009 VL HIV MON-1 13 A 5 2
P Patient 14 MHOM/FR/2000/LPM197 2000 VL HIV MON-1 14 A 5 2
AM Patient 15 MHOM/FR/97/LPN161 1997 CL MON-1 15 A 1 4
CO Patient 16 MHOM/FR/97/LPN154 1997 VL MON-1 16 A 6 3
P Patient 17 MHOM/FR/2002/LPM225 2002 VL HIV MON-1 17 A 5 2
P Patient 18 MHOM/FR/2002/LPM215 2002 VL HIV MON-1 17 A 5 2
P Patient 19 MHOM/FR/2000/LPM
195
2000 VL HIV MON-1 18 A 2/5/3 1/3/2
AM Patient 20 MHOM/FR/86/LPN30 1986 VL HIV MON-1 19 A/
B
AM Patient 21 MHOM/FR/88/LPN50 1988 VL HIV MON-1 20 A 5 2
AM Patient 29 MHOM/FR/84/LPN23 1984 VL MON-1 21 A 5 2
AM Patient 30 MHOM/FR/85/LPN25a 1985 VL MON-1 21 A 5 2
AM Patient 31 MHOM/FR/94/LPN112 1994 VL MON-1 21 A 5 2
P Patient 22 MHOM/FR/96/LPM151 1996 VL HIV MON-1 21 A 5 2
AM Patient 32 MHOM/FR/96/LPN132 1996 VL MON-1 21 A 5 2
P Patient 23 MHOM/FR/97/LPM169 1997 VL HIV MON-1 21 A 5 2
P Patient 24 MHOM/FR/97/LPM172 1997 VL HIV MON-1 21 A 5 2
P Patient 35 MHOM/FR/2004/LPN228 2004 IVL MON-1 21 A 5 2
P Patient 25 MHOM/FR/2005/LPM242 2005 IVL MON-1 21 A 5 2
P Patient 26 MHOM/FR/2005/LPM247 2005 IVL MON-1 21 A 5 2
P Patient 27 MHOM/FR/2009/LPM261 2009 IVL MON-1 21 A 5 2
AM MCAN/FR/95/LPN122* CanL MON-1 21 A 5 2
AM MCAN/FR/95/LPN123* CanL MON-1 21 A 5 2
AM MCAN/FR/95/LPN124* CanL MON-1 21 A 5 2
AM Patient 33 MHOM/FR/96/LPN136* 1996 AC MON-1 21 A 5 2
AM Patient 34 MHOM/FR/96/LPN131* 1996 AC MON-1 21 A 5 2
AM Patient 28 MHOM/FR/81/LPN5 1981 IVL MON-1 21 A 5 2
AM Patient 36 n. d. 2009 IVL MON-1 21 A 5 2
(Continued)
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Table 1. (Continued)
Endemic
area
Patients Sample WHO code Y C F /
H
HIV
status
Zymo G P Sub-Pop
A
Sub-Pop
A
Sub-Pop
B
K = 6 K = 4 K = 2
AM Patient 37 MHOM/FR/90/LPN61 1990 IVL MON-1 22 A/
B
AM Patient 38 MHOM/FR/2002/LPN199 2002 VL MON-1 23 A 3 1
P Patient 39 MHOM/FR/2007/LPM255 2007 IVL MON-1 24 A 4/5/2 1
P Patient 40 MHOM/FR/2002/LPM216 2002 VL HIV MON-1 25 A 4/3/2 1
P Patient 41 MHOM/FR/2002/LPM217 2002 VL MON-1 25 A 4/3/2 1
P Patient 42 MHOM/FR/98/LPM185 1998 VL HIV MON-1 26 A 4/5/6 1
CO Patient 43 MHOM/FR/2006/LPM251 2006 IVL MON-24 27 A 2 1
AM Patient 44 MHOM/FR/2001/LPN195 2001 VL MON-1 28 A 5/2/4 1/2
AM Patient 45 MHOM/FR/2007/LPN312 2007 IVL MON-1 29 A 3 1
AM MCAN/FR/86/LPN28 1986 CanL MON-1 30 A 3 1
P Patient 46 MHOM/FR/2003/LPN221 2003 CL MON-1 31 A 3/2 1
AM Patient 47 MHOM/FR/97/LPN159 1997 VL MON-1 32 B/
A
AM Patient 48 MHOM/FR/90/LPN64 1990 VL HIV MON-1 33 A 3 1
AM Patient 49 MHOM/FR/89/LPN54 1989 VL MON-1 34 B 1
AM Patient 50 MHOM/FR/91/LPN70 1991 IVL MON-1 34 B 1
AM Patient 51 MHOM/FR/92/LPN78 1992 VL MON-1 34 B 1
AM Patient 52 MHOM/FR/95/LPN116 1995 VL HIV MON-1 34 B 1
AM Patient 53 MHOM/FR/96/LPN141 1996 VL MON-1 34 B 1
AM Patient 54 MHOM/FR/97/LPN150 1997 IVL MON-1 34 B 1
AM Patient 55 MHOM/FR/2001/LPN181 2001 IVL MON-1 34 B 1
AM Patient 56 MHOM/FR/2007/LPN313 2007 CL MON-1 34 B 1
AM Patient 57 MHOM/FR/2011/LPN358 2011 VL MON-1 34 B 1
AM MCAN/FR/89/LPN57 1989 CanL MON-1 35 A/
B
AM Patient 58 MHOM/FR/95/LPN120 1995 VL HIV MON-1 35 A/
B
AM Patient 60 MHOM/FR/92/LPN84 1992 IVL MON-1 36 A 3 1
AM Patient 61 MHOM/FR/94/LPN103 1994 CL MON-1 36 A 3 1
AM Patient 62 MHOM/FR/95/LPN115 1995 IVL MON-1 36 A 3 1
AM Patient 63 MHOM/FR/95/LPN119 1995 VL HIV MON-1 36 A 3 1
CO Patient 59 MHOM/FR/96/LPM157 1996 VL MON-1 36 A 3 1
AM Patient 64 MHOM/FR/2001/LPN187 2001 VL MON-1 36 A 3 1
AM Patient 64 MHOM/FR/2002/LPN198 2002 RVL MON-1 36 A 3 1
P Patient 65 MHOM/FR/94/LPM112 1994 VL HIV MON-1 37 A 4/5/1 1/2/4
P Patient 66 MHOM/FR/2006/LPM250 2006 VL MON-1 37 A 4/5/1 1/2/4
AM Patient 67 MHOM/FR/93/LPN92 1993 VL HIV MON-1 38 A 2/1/3 3/4/1
P Patient 68 MHOM/FR/97/LPM173 1997 VL MON-1 39 B 1
AM Patient 69 MHOM/FR/86/LPN29 1986 VL HIV MON-1 40 A/
B
AM Patient 71 MHOM/FR/87/LPN33 1987 IVL MON-1 41 A/
B
AM MCAN/FR/87/LPN34 1987 CanL MON-1 41 A/
B
AM Patient 72 MHOM/FR/89/LPN51 1989 VL HIV MON-1 41 A/
B
(Continued)
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Table 1. (Continued)
Endemic
area
Patients Sample WHO code Y C F /
H
HIV
status
Zymo G P Sub-Pop
A
Sub-Pop
A
Sub-Pop
B
K = 6 K = 4 K = 2
AM Patient 73 MHOM/FR/98/LPN164 1998 VL HIV 41 A/
B
AM Patient 70 MHOM/FR/2005/LPM244 2005 VL HIV MON-1 41 A/
B
AM Patient 74 MHOM/FR/96/LPN146 1996 VL HIV MON-1 42 B 2
AM Patient 75 MHOM/TR/94/LPN101 1994 IVL MON-1 43 B 1
AM Patient 76 MHOM/FR/94/LPN104 1994 IVL MON-1 43 B 1
AM Patient 77 MHOM/FR/95/LPN113 1995 IVL MON-1 43 B 1
AM Patient 78 MHOM/FR/95/LPN121 1995 VL HIV MON-1 43 B 1
AM Patient 86 MHOM/FR/2002/LPN201 2002 RVL HIV MON-1 43 B 1
AM Patient 87 MHOM/FR/2004/LPN233 2004 VL HIV MON-1 43 B 1
AM Patient 79 MHOM/FR/96/LPN134* 1996 AC MON-1 43 B 1
AM Patient 80 MHOM/FR/96/LPN137* 1996 AC MON-1 43 B 1
AM Patient 81 MHOM/FR/96/LPN138* 1996 AC MON-1 43 B 1
AM Patient 82 MHOM/FR/96/LPN144* 1996 AC MON-1 43 B 1
AM Patient 83 MHOM/FR/96/LPN143* 1996 AC MON-1 43 B 1
AM Patient 84 MHOM/FR/96/LPN142* 1996 AC MON-1 43 B 1
AM Patient 85 MHOM/IT/96/LPN145* 1996 AC MON-1 43 B 1
AM Patient 88 MHOM/FR/80/LPN3 1980 IVL MON-1 44 B 1
AM Patient 89 MHOM/00/94/LPN108 1994 VL HIV MON-1 44 B 1
AM Patient 90 MHOM/FR/2004/LPN236 2004 VL MON-1 45 B 1
AM MCAN/FR/82/LPN16 1983 CanL MON-1 46 B 1
AM Patient 91 MHOM/FR/83/LPN19 1983 VL MON-1 46 B 1
AM Patient 92 MHOM/FR/84/LPN20 1984 VL MON-1 46 B 1
AM Patient 93 MHOM/FR/85/LPN24 1985 VL MON-1 46 B 1
AM MCAN/FR/87/LPN37 1987 CanL MON-1 46 B 1
AM Patient 94 MHOM/FR/88/LPN46 1988 VL MON-1 46 B 1
AM Patient 95 MHOM/FR/89/LPN59 1989 VL HIV MON-1 46 B 1
AM Patient 96 MHOM/FR/93/LPN91 1993 IVL MON-1 46 B 1
AM Patient 97 MHOM/00/93/LPN94 1993 VL HIV MON-1 46 B 1
AM Patient 98 MHOM/FR/95/LPN107 1994 IVL MON-1 46 B 1
AM Patient 99 MHOM/FR/95/LPN114 1994 IVL MON-1 46 B 1
AM Patient
100
MHOM/FR/95/LPN118 1995 VL HIV MON-1 46 B 1
AM Patient
101
MHOM/FR/96/LPN125 1996 VL MON-1 46 B 1
AM Patient
102
MHOM/FR/97/LPN148 1997 VL HIV MON-1 46 B 1
P Patient
105
MHOM/FR/97/LPM139 1995 VL HIV MON-1 46 B 1
AM Patient
103
MHOM/FR/97/LPN152 1997 VL MON-1 46 B 1
AM Patient
104
MHOM/FR/2001/LPN180 2001 IVL MON-1 46 B 1
AM Patient
106
MHOM/FR/2005/LPN257 2005 IVL MON-1 47 B 1
AM Patient
107
MHOM/FR/84/LPN21 1984 VL MON-1 48 B 1
(Continued)
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Table 1. (Continued)
Endemic
area
Patients Sample WHO code Y C F /
H
HIV
status
Zymo G P Sub-Pop
A
Sub-Pop
A
Sub-Pop
B
K = 6 K = 4 K = 2
AM Patient
108
MHOM/FR/92/LPN85 1992 IVL MON-1 48 B 1
AM Patient
109
MHOM/FR/2004/LPN240 2004 VL MON-1 48 B 1
AM Patient
110
n. d. 2011 IVL MON-1 49 B 1
AM Patient
111
MHOM/FR/92/LPN86 1992 IVL MON-1 50 B 2
AM Patient
112
MHOM/FR/2001/LPN191 2001 VL HIV MON-1 50 B 2
AM Patient
113
MHOM/FR/2008/LPN321 2008 VL MON-1 50 B 2
AM Patient
114
MHOM/FR/99/LPN170 1999 VL MON-1 51 B 2
AM Patient
115
MHOM/FR/2006/LPN281 2006 VL MON-1 52 B 2
CE MCAN/FR/2006/LPN285 2006 CanL MON-1 52 B 2
AM Patient
116
MHOM/FR/87/LPN36 1987 VL HIV MON-1 53 B 2
AM Patient
117
MHOM/FR/91/LPN71 1991 VL HIV MON-1 53 B 2
AM Patient
118
MHOM/FR/93/LPN96 1992 VL MON-1 53 B 2
AM Patient
119
MHOM/FR/93/LPN99 1993 VL HIV MON-1 53 B 2
AM MCAN/FR/94/LPN102 1994 CanL MON-1 53 B 2
AM Patient
120
MHOM/FR/95/LPN117 1995 VL MON-1 53 B 2
AM Patient
121
MHOM/FR/2001/LPN189 2001 VL MON-1 53 B 2
AM Patient
122
MHOM/FR/78/LPN1 1978 VL MON-1 54 B 2
AM MCAN/FR/82/LPN6 1982 CanL MON-1 55 B 2
AM Patient
123
MHOM/FR/84/LPN22 1983 VL MON-1 55 B 2
AM Patient
124
MHOM/FR/86/LPN31 1986 VL MON-1 55 B 2
AM Patient
125
MHOM/FR/88/LPN48 1988 CL MON-1 55 B 2
AM Patient
126
MHOM/FR/89/LPN55 1989 IVL MON-1 55 B 2
AM Patient
127
MHOM/FR/90/LPN68 1990 IVL MON-1 55 B 2
AM Patient
128
MHOM/FR/92/LPN76 1992 VL MON-1 55 B 2
AM Patient
129
MHOM/FR/92/LPN77 1992 VL HIV MON-1 55 B 2
AM Patient
130
MHOM/FR/92/LPN80 1992 VL HIV MON-1 55 B 2
AM Patient
131
MHOM/FR/92/LPN82 1992 VL HIV MON-1 55 B 2
(Continued)
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Table 1. (Continued)
Endemic
area
Patients Sample WHO code Y C F /
H
HIV
status
Zymo G P Sub-Pop
A
Sub-Pop
A
Sub-Pop
B
K = 6 K = 4 K = 2
CO Patient
146
MHOM/FR/93/LPN95 1993 VL MON-1 55 B 2
AM Patient
132
MHOM/FR/94/LPN106 1994 VL MON-1 55 B 2
AM Patient
133
MHOM/FR/94/LPN109 1994 VL HIV MON-1 55 B 2
AM Patient
135
MHOM/FR/96/LPN133 1996 IVL MON-1 55 B 2
AM Patient
134
MHOM/FR/96/LPN130 1996 VL MON-1 55 B 2
AM MFEL/FR/96/LPN139 1996 CatL MON-1 55 B 2
AM Patient
136
MHOM/FR/97/LPN155 1997 VL MON-1 55 B 2
AM Patient
137
MHOM/FR/97/LPN158 1997 VL MON-1 55 B 2
AM Patient
139
MHOM/FR/2000/LPN176 2000 VL MON-1 55 B 2
AM Patient
138
MHOM/FR/2000/LPN175 2000 VL MON-1 55 B 2
AM Patient
140
MHOM/FR/2003/LPN209 2003 IVL MON-1 55 B 2
AM Patient
141
MHOM/FR/2003/LPN217 2003 VL MON-1 55 B 2
AM Patient
142
MHOM/FR/2006/LPN259 2006 VL MON-1 55 B 2
AM Patient
143
MHOM/FR/2006/LPN282 2006 IVL MON-1 55 B 2
AM Patient
144
MHOM/FR/2007/LPN316 2007 VL MON-1 55 B 2
AM Patient
145
MHOM/FR/2011/LPN357 2011 VL MON-1 55 B 2
AM Patient
147
MHOM/FR/96/LPN127 1996 VL HIV MON-1 56 B 2
AM MCAN/FR/82/LPN10 1982 CanL MON-1 57 B 2
AM Patient
148
MHOM/FR/89/LPN53 1989 VL MON-1 57 B 2
AM Patient
149
MHOM/FR/90/LPN66 1990 VL MON-1 57 B 2
AM Patient
150
MHOM/FR/93/LPN90 1993 VL MON-1 57 B 2
AM Patient
151
MHOM/FR/93/LPN93 1993 IVL MON-1 57 B 2
AM Patient
152
MHOM/FR/93/LPN98 1993 VL HIV MON-1 57 B 2
AM Patient
153
MHOM/FR/94/LPN110 1994 VL HIV MON-1 57 B 2
AM Patient
154
MHOM/FR/96/LPN140 1996 IVL MON-1 57 B 2
AM Patient
155
MHOM/FR/97/LPN156 1997 VL HIV MON-1 57 B 2
AM Patient
156
MHOM/FR/2000/LPN178 2000 IVL MON-1 57 B 2
(Continued)
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Table 1. (Continued)
Endemic
area
Patients Sample WHO code Y C F /
H
HIV
status
Zymo G P Sub-Pop
A
Sub-Pop
A
Sub-Pop
B
K = 6 K = 4 K = 2
AM Patient
157
MHOM/FR/2001/LPN190 2001 IVL MON-1 57 B 2
AM Patient
158
MHOM/FR/2006/LPN277 2006 VL MON-1 57 B 2
AM Patient
159
MHOM/FR/2011/LPN351 2011 IVL MON-1 57 B 2
AM Patient
160
MHOM/FR/2011/LPN356 2011 IVL MON-1 57 B 2
AM Patient
161
MHOM/FR/2011/LPN366 2011 IVL MON-1 57 B 2
AM Patient
162
MHOM/FR/2004/LPN237 2004 VL MON-1 58 B 2
CO Patient
163
MHOM/FR/94/LPN105 1994 VL HIV MON-1 59 B 1
P Patient
164
MHOM/FR/96/LPM154 1996 IVL MON-1 60 A 3/4/5/2 1
P Patient
165
MHOM/FR/97/LPM174 1997 VL HIV MON-1 61 A 4/3/2 1
AM Patient
166
MHOM/FR/99/LPN173 1999 IVL MON-1 62 A/
B
P Patient
167
MHOM/FR/97/LPM170 1997 IVL MON-1 63 A 1 4
P Patient
168
MHOM/FR/97/LPM177 1997 VL HIV MON-1 63 A 1 4
P Patient
169
MHOM/FR/2000/LPM201 2000 VL HIV MON-1 63 A 1 4
P Patient
170
MHOM/FR/2001/LPM209 2001 VL HIV MON-1 64 A 1/3/4/2 4/1/2
P Patient
171
MHOM/FR/97/LPM166 1997 VL HIV MON-1 65 A 1 4
P Patient
172
MHOM/FR/2004/LPM236 2004 IVL MON-1 66 A 1 4
P Patient
173
MHOM/FR/2006/LPM252 2006 VL MON-1 67 A 1 4
P Patient
174
MHOM/FR/94/LPM116 1994 VL HIV MON-1 68 A 1 4
P Patient
175
MHOM/FR/96/LPM138 1996 VL HIV MON-1 68 A 1 4
P Patient
176
MHOM/FR/99/LPM189 1999 IVL MON-1 68 A 1 4
P Patient
177
MHOM/FR/2000/LPM204 2000 IVL MON-1 68 A 1 4
P Patient
178
MHOM/FR/98/LPM183 1998 VL HIV MON-1 69 A 1/3/2 4
P Patient
179
MHOM/FR/97/LPM178 1997 UK MON-1 69 A 1/3/2 4
P Patient
180
MHOM/FR/2003/LPM232 2003 IVL MON-1 70 A 1 4
P Patient
181
MHOM/FR/96/LPM152 1996 VL MON-1 71 A 1/3/2 4
P Patient
182
MHOM/FR/97/LPM168 1997 VL HIV MON-1 72 A 1 4
(Continued)
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Table 1. (Continued)
Endemic
area
Patients Sample WHO code Y C F /
H
HIV
status
Zymo G P Sub-Pop
A
Sub-Pop
A
Sub-Pop
B
K = 6 K = 4 K = 2
P Patient
183
MHOM/FR/98/LPM181 1998 MCL MON-1 73 A 5 2
P Patient
184
MHOM/FR/96/LPM156 1996 IVL MON-1 74 A 5/1/4/2 2/4/1
CE IPER/FR/84/LEM576* 1984 PHLE MON-1 75 A 4/1/2 1/4
CE IARI/FR/84/LEM595* 1984 PHLE MON-1 75 A 4/1/2 1/4
AM Patient
185
MHOM/FR/96/LPN129 1996 VL HIV MON-1 76 A 1 4
AM Patient
186
MHOM/FR/88/LPN45 1988 VL HIV MON-1 77 A 1 4
AM Patient
187
MHOM/FR/89/LPN58 1989 IVL MON-1 77 A 1 4
AM Patient
188
MHOM/FR/91/LPN69 1991 VL HIV MON-1 77 A 1 4
AM Patient
189
MHOM/FR/96/LPN128 1996 VL HIV MON-1 77 A 1 4
AM Patient
190
MHOM/FR/97/LPN151 1996 VL HIV MON-1 77 A 1 4
AM Patient 86 MHOM/FR/97/LPN153 1997 VL HIV MON-1 77 A 1 4
AM MCAN/FR/98/LPN168 1998 CanL 77 A 1 4
AM Patient 86 MHOM/FR/2000/LPN177 2000 RVL HIV MON-1 77 A 1 4
AM Patient 86 MHOM/FR/2001/LPN185 2001 RVL HIV MON-1 77 A 1 4
AM Patient
191
MHOM/FR/2001/LPN186 2001 VL HIV MON-1 77 A 1 4
AM Patient 86 MHOM/FR/2003/LPN215 2003 RVL HIV MON-1 77 A 1 4
AM Patient
192
MHOM/FR/2007/
LPN314*
2007 VL HIV MON-1 78 A 1/6 4/3/1
AM MCAN/FR/2006/LPN267 2006 CanL MON-1 79 A 1/6/3/4 4/2/3
P Patient
193
MHOM/FR/2002/LPM222 2002 VL HIV MON-1 80 A 1/5/6 4/2
P Patient
194
MHOM/FR/2001/LPM214 2001 VL MON-1 81 A 2/4 1
P Patient
195
MHOM/FR/2002/LPM226 2002 VL HIV MON-1 82 A 2/4 1
P Patient
196
MHOM/FR/2002/LPM228 2002 VL MON-1 83 A 2/4 1
P Patient
197
MHOM/FR/96/LPM155 1996 VL MON-1 84 A 2/3/1 1
P Patient
198
MHOM/FR/96/LPM159 1996 VL MON-1 84 A 2/3/1 1
P Patient
199
MHOM/FR/94/LPM133 1994 VL HIV MON-1 85 A 2 1
P Patient
200
MHOM/FR/96/LPM161 1996 IVL HIV MON-1 85 A 2 1
P Patient
201
MHOM/FR/2009/LPM264 2009 MCL MON-1 85 A 2 1
P Patient
202
MHOM/FR/94/LPM122-2 1994 VL HIV MON-1 86 A 1/3/4 4/1
P Patient
203
MHOM/FR/2001/LPM212 2001 CL MON-1 87 A 4/3/2 1
(Continued)
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Table 1. (Continued)
Endemic
area
Patients Sample WHO code Y C F /
H
HIV
status
Zymo G P Sub-Pop
A
Sub-Pop
A
Sub-Pop
B
K = 6 K = 4 K = 2
P Patient
204
MHOM/FR/2008/LPM260 2008 VL HIV MON-1 88 A 2 1/3
P Patient
205
MHOM/FR/99/LPM191 1999 CL HIV MON-1 89 A 1/3 1/4
P Patient
206
MHOM/FR/95/LPM137 1995 VL HIV MON-1 90 A 3/6 1/3
P Patient
207
MHOM/FR/2000/LPM196 2000 VL HIV MON-1 91 A 4 1
P Patient
208
MHOM/FR/94/LPM118 1994 VL HIV MON-
108
92 A 4/1/5 1/2/4
CE Patient
212
MHOM/FR/85/LEM716* 1985 VL MON-1 93 A 4 1
P Patient
210
MHOM/FR/97/LPM176 1997 IVL MON-1 93 A 4 1
CO Patient
209
MHOM/FR/98/LPM186 1998 VL MON-1 93 A 4 1
P Patient
211
MHOM/FR/2001/LPN183 2001 VL MON-1 93 A 4 1
AM Patient
213
MHOM/FR/83/LPN18 1983 VL MON-1 94 A 4 1
CE Patient
214
MHOM/FR/87/LEM1098* 1987 CL MON-1 94 A 4 1
CE Patient
215
MHOM/FR/78/LEM75* 1978 VL MON-1 94 A 4 1
CE Patient
216
MHOM/FR/85/LEM663* 1985 VL MON-1 95 A 4 1
AM Patient
217
MHOM/FR/88/LPN41 1988 VL HIV MON-1 96 A 2/5 3/2
AM Patient
218
MHOM/FR/2003/LPN213 2003 VL MON-1 97 A 4 1
AM Patient
219
MHOM/FR/96/LPM162 1996 CL MON-24 98 A 6 3
AM Patient
220
MHOM/00/2004/LPN234 2004 CL MON-24 99 A 6 3
AM Patient
190
MHOM/FR/2001/LPN182 2001 RVL HIV MON-1 100 A 1 4
AM Patient
190
MHOM/FR/2001/LPN188 2001 RVL HIV MON-1 100 A 1 4
P Patient
221
MHOM/FR/2000/LPM200 2000 VL HIV MON-1 101 A 2/1 1/3/4
P Patient
222
MHOM/FR/94/LPM120 1994 VL HIV MON-1 102 A 2/1/3 1/4
P Patient
223
MHOM/FR/99/LPM194 1999 MCL MON-1 103 A 4/3/2 1
P Patient
224
MHOM/FR/96/LPM158 1996 VL MON-1 104 A 4/2/5 1/2
AM MCAN/FR/80/LPN4 1980 CanL MON-1 105 A 4/3/2 1
AM MCAN/FR/82/LPN8 1982 CanL MON-1 105 A 4/3/2 1
AM Patient
225
MHOM/FR/99/LPN171 1999 IVL MON-1 106 A 3 1
P Patient
226
MHOM/FR/2001/LPM211 2001 VL HIV MON-1 107 A 3 1
(Continued)
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strain MHOM/FR/85/LEM716 was used as a control to determine the size of amplified micro-
satellite fragments, as this microsatellite data have been published [9].
Multi-Locus Microsatellite Typing (MLMT)
Twelve microsatellite loci were amplified using the PCR conditions as previously described:
LiBTG, LiBTA, LIST7021, LIST7025, LIST7026, LIST7031, LIST7033, Li22-25, Li45-24,
TubCA, Li71-5/2 and Rossi2 [9–12]. The amplification products were analyzed using an auto-
mated capillary ABI Prism 3130XL Genetic Analyzer (Applied Biosystems, France). The data
were stored and analyzed using GeneMapper analysis software (version 4.0, Applied Biosys-
tems). PCR fragment sizes were determined using the internal size standard GeneScan 500 LIZ
(Applied Biosystems). All 270 Leishmania isolates were genotyped at each of the 12 loci. With
the PCR fragment size of the control strain MHOM/FR/85/LEM716, we were able to include
Table 1. (Continued)
Endemic
area
Patients Sample WHO code Y C F /
H
HIV
status
Zymo G P Sub-Pop
A
Sub-Pop
A
Sub-Pop
B
K = 6 K = 4 K = 2
P Patient
227
MHOM/00/00/LPM148 1995 UK MON-1 108 A 3 1
AM Patient
228
n. d. 2011 VL MON-1 109 A 3 1
AM MCAN/FR/86/LPN27 1986 CanL MON-1 110 A 3 1
AM Patient
229
MHOM/FR/99/LPN174 1999 CL MON-24 111 A 6 3
AM Patient
230
MHOM/FR/2005/LPN253 2001 VL HIV MON-80 112 A 6 3
P Patient
231
MHOM/00/2003/LPM233 2003 IVL MON-1 113 A 2 3
CO Patient
232
MHOM/FR/2000/LPM205 2000 VL MON-1 114 A 6 3
CO Patient
233
MHOM/FR/92/LPN83 1991 CL HIV MON-1 115 A 6 3
CO Patient
234
MHOM/FR/99/LPM190 1999 VL HIV MON-1 116 A 6 3
AM Patient
235
MHOM/FR/89/LPN60 1989 VL HIV MON-1 117 A 2 1/3
P Patient
236
MHOM/FR/2008/LPM259 2008 VL HIV MON-1 118 A 2/1 1/4/3
P Patient
237
MHOM/FR/2007/LPM254 2007 IVL MON-1 119 A 6 3
AM Patient
238
MHOM/FR/93/LPN97 1993 CL MON-24 120 A 6 3
P Patient
239
MHOM/FR/95/LPM136 1995 VL HIV MON-1 121 A 6 3
Legend of columns: Endemic area: AM: Alpes-Maritimes; P: Provence; CE: Cévennes; CO: Corsica. Patients: Anonymized name given to the patients.
Sample WHO code: WHO code of the isolates; The MLMT proﬁle of the samples indicated with * was already characterized by Hide et al [9]; n. d. = not
deﬁned. Y: Year of isolation. C F / H: Clinical form of the disease and/or host: VL–visceral leishmaniasis; IVL–Infant under 15 years with visceral
leishmaniasis; CL–cutaneous leishmaniasis; MCL–muco-cutaneous leishmaniasis; RVL—New episode of leishmaniasis in VL patient; AC–asymptomatic
carrier; CanL–canine leishmaniasis; CatL–leishmaniasis in cat; PHLE–sample isolated from phlebotomine sandﬂy; UK–unknown. Zymo: zymodeme of
isolate. G: genotypes. P: population as deﬁned by STRUCTURE.
doi:10.1371/journal.pntd.0004303.t001
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microsatellite data from the Hide et al. study (data indicated with an asterisk in Table 1). Four
isolates from this previous study (MCAN/FR/95/LPN122, MCAN/FR/95/LPN123, MCAN/FR/
95/LPN124, and MCAN/FR/95/LPN124) were re-extracted from culture and re-genotyped
blindly. The same microsatellite results described by Hide et al. were obtained [8].
Genetic diversity and differentiation analysis
Descriptive statistics for the observed genetic populations were calculated using Genetix ver-
sion 4.05.2 (2004) and FSTAT Version 2.9.3.2 [13]. Using these programs, we calculated allelic
diversity (number of allelic variants per maker), expected (He) and observed (Ho) heterozygos-
ity, genetic diversity within subsamples Hs, inbreeding coefficient (FIS) the migration rates
(gene flow) (Nm) [14]. The Fst value, which indicates the degree of genetic differentiation
and gene flow among populations was also calculated. Fst values above 0.25 with significant p-
values (<0.05) indicated strong genetic differentiation [15].
Clustering and phenetic analyses
Phylogenetic analyses were performed based on the microsatellite profiles. A distance matrix
was calculated using the Chord distance (Cavalli-Sforza and Edwards 1967) setting in the POP-
ULATIONS 1.2.31 software with bootstrap values determined for 1,000 replicates (http://
bioinformatics.org/~tryphon/populations/) [16]. The resulting distance matrix was processed
using MEGA 4.0.2 to construct an unrooted Neighbor-Joining (NJ) tree [17].
Fig 1. Geographical distribution of isolates from Southeastern France. Isolates clustered into four endemic areas. The geographic areas where samples
were isolated from Cévennes (blue), Provence (green), Alpes-Maritimes (red) and Corsica (violet) are indicated. The Alpes-Maritimes and Provence endemic
areas are located in the PACA region.
doi:10.1371/journal.pntd.0004303.g001
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The genetic characteristics of the Leishmania samples were also investigated using a model-
based Bayesian clustering method implemented in STRUCTURE v 2.3.4 [18]. This algorithm
simultaneously estimates the allele frequencies to assign individuals into genetically distinct
populations (K) and each probability for the identification of the most likely number of popula-
tions. A series of ten independent runs was performed for each K value between one and ten.
The following parameters were used: burn in period of 20,000 iterations, 200,000 Markov
Chain Monte Carlo iterations and admixture model. The most probable number of clusters
was identified via calculation of the Delta K (ΔK), which is based on the rate of change in the
log probability of data between successive K values. The peak of the ΔK graph corresponds to
the most probable number of populations in the data set [19].
Statistical analysis
A chi-square statistical test was performed to determine whether the observed data differed sig-
nificantly from the expected ratios. The chi-square value was considered significant when
p0.05. This test was used to compare the proportion of HIV+ patients in Populations A and B.
Results
Microsatellite analysis
In total, 270 isolates were typed at 12 microsatellite markers with one or two alleles at each
locus. All markers were polymorphic. The number of alleles per locus (Na) ranged from 3 to
13. Li22-35, LIST7021, LiBTG, LiBTA and LIST7026 were the most polymorphic markers with
13, 12, 10, 9 and 8 alleles, respectively. LIST7031, Li71-5/2 and LIST7025 were the least poly-
morphic markers with three different alleles (Table 2).
Genetic variability was analyzed among the 12 microsatellite loci (Table 2). TheHo was weak
and ranged from 0.011 to 0.174 for Li71-5/2 and LiBTA, respectively, with an overallHo at 0.044.
The mean intra-populationHs was 0.546 (0.224–0.811) for the entire sample set and 0.531
(0.208–0.804) for the MON-1 population (Table 2). The FIS for the entire population was 0.920,
thereby indicating a considerable degree of inbreeding. A separate analysis was performed to
investigate the genetic polymorphisms among the four geographically determined populations
(Table 3). Extensive inbreeding in the four populations was observed, with the highest inbreeding
coefficient found in the populations of the CO and AM endemic areas. The genetic differentia-
tion among the four endemic areas was tested using FSTAT version 2.9.3.2 (Table 4). The Fst val-
ues ranged from 0.067 to 0.321. All Fst values between the four endemic areas were significant.
We obtained lower values for P versus CE and P versus CO and higher values for AM versus CE
and CO versus CE (which may be due to the low number of isolates collected from CE and CO).
When comparing AM and P samples from 1993 to 2009 (corresponding to the time period of the
isolation of samples from the P endemic area used in this study), the Fst value obtained was simi-
lar to the Fst value corresponding to the complete period of sample collection (1978 to 2011).
Sub-populations were also defined according to their position in relation to Vars River (S1
Table). This river is located in the southeast of France and flows in the Alpes-Maritimes
Department. The Fst values highlighted a gradient of differentiation from the East Vars to the
West Vars and up to the P endemic area. A high and significant genetic differentiation
(Fst = 0.308) was obtained when comparing isolates from east of the Vars River and the P
endemic area. The comparison of sub-populations isolated from the P endemic area failed to
show any genetic differentiation (Marseille versus Toulon or Marseille versus other cities in the
P endemic area), with the limitation that few samples were collected from Toulon (n = 7).
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Geographical distribution of isolates from the two main endemic areas of
AM and P
A total of 121 different genotypes were identified from the 270 isolates corresponding to a geno-
type frequency of 0.037. The entire sample set comprised 91 unique genotypes (75%). Among
the 30 repeated genotypes, seven were common to two endemic areas, one was common to three
endemic areas and 22 pertained to the same focus (Fig 2). The genotypes 21 (primarily) and 46
were found in both endemic areas of AM and P (Fig 2). Within these endemic areas, Faucher
et al. have described high- and low-risk sub-areas of VL [5]. In our study, the repeated genotypes
were almost exclusively found in high-risk areas, with the only exception of genotype 21 which
was found in high and low risk sub-areas (Fig 3A and 3B). Among the 30 repeated genotypes, 11
were found in four or more samples. These 11 genotypes represented 132 isolates.
Temporal analysis of genotypes
The isolates were collected over the course of a 33-year period from 1978 to 2011 (Fig 4). The
repeated genotypes, found in four or more samples, were isolated over a period of six (genotype
68) to 29 years (genotypes 57 and 55). All genotypes except 68, 36, 34 and 43 were isolated
from both humans and dogs. Genotype 21 was found to be present in the AM and P endemic
areas over the course of 28 years. This genotype was first isolated in 1981 in the AM endemic
Table 2. Descriptive statistics of the 270 isolates analyzed at the 12microsatellite markers.
Locus Na He Ho Hs FIS
Li22-35 13 0.644 0.082 0.645 0.874
LIST7021 12 0.547 0.037 0.548 0.933
LiBTG 10 0.620 0.041 0.621 0.935
LiBTA 9 0.809 0.174 0.811 0.786
LIST7026 8 0.690 0.033 0.691 0.952
TubCA 7 0.541 0.041 0.542 0.925
Li45-24 6 0.649 0.026 0.650 0.960
Rossi2 6 0.553 0.019 0.554 0.967
LIST7033 6 0.533 0.019 0.534 0.965
LIST7031 3 0.230 0.026 0.231 0.888
LIST7025 3 0.240 0.019 0.224 0.918
Li71-5/2 3 0.502 0.011 0.503 0.978
Overall 7.17 0.545 0.044 0.546 0.920
Na: number of alleles per locus; He: expected heterozygosity; Ho: observed heterozygosity; Hs: genetic diversity; FIS: inbreeding coefﬁcient.
doi:10.1371/journal.pntd.0004303.t002
Table 3. Genetic diversity among the four endemic areas based on the MLMT profiles of the 12 ana-
lyzedmarkers.
Na He Ho FIS
AM 6.333 0.462 0.030 0.936
P 5.417 0.498 0.079 0.844
CO 3.000 0.568 0.028 0.956
CE 2.250 0.281 0.042 0.869
Na: Number of alleles per locus, He: expected heterozygosity, Ho: observed heterozygosity, FIS: inbreeding
coefﬁcient.
AM = Alpes-Maritimes, P = Provence, CO = Corsica and CE = Cévennes.
doi:10.1371/journal.pntd.0004303.t003
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area and then in 1996, at which time it was first identified in both the AM and P endemic
areas. After 1996, genotype 21 was only isolated in the P. Finally, in 2009, this genotype was
found in both the AM and P endemic areas. Genotype 21 was isolated from a variety of patients
including asymptomatic carriers (AC), adult VL, infant VL and HIV+ VL cases.
Relapse and re-infection
Four patients (patients 4, 64, 86 and 190) experienced more than one episode of VL (Table 1).
Three of these patients were HIV+ (patients 4, 86 and 190). The isolates derived from patient 4
and 64 (HIV+ and HIV-, respectively), which were collected during a first VL episode (2003 for
patient 4 and 2001 for patient 64) and second VL episode (one year later), presented identical
MLMT profiles. In both cases, relapse was suspected. Patient 190 (HIV+) presented three episodes
of VL, for which the second and third (2001 for both episodes) isolates differed from the first
Table 4. Genetic differentiation between the isolates from the four endemic areas analyzed using F-
statistics with the corresponding p-values.
Endemic areas Number of
isolates
Fst p-
value
P vs. AM 75 / 178 0.239 0.008
P vs. CO 75 / 9 0.126 0.008
P vs. CE 75 / 8 0.067 0.050
CO vs. CE 9 / 8 0.270 0.008
AM vs. CO 178 / 9 0.161 0.008
AM vs. CE 178 / 8 0.321 0.008
P vs. AM isolates collected during same period of time (1993 to
2009)
75 / 111 0.236 0.050
Sub-population deﬁned according to their position in relation to
the Vars river
AM East Vars vs. AM West Vars 122 / 50 0.062 0.050
AM West Vars vs. P 52 / 75 0.144 0.050
P vs. AM East Vars 75 / 122 0.308 0.050
Sub-population within the P endemic area
Within P: Marseille vs. Toulon 42 / 7 0.033 0.850
Within P: Marseille vs. Other cities In P 42 / 33 0.012 0.550
doi:10.1371/journal.pntd.0004303.t004
Fig 2. Repeated genotypes. Arbitrary numbers assigned to the 30 repeated genotypes in (x-axis) and number of isolates belonging to each genotype (y-
axis). The origin of each isolates is indicated by the different colors.
doi:10.1371/journal.pntd.0004303.g002
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Fig 3. A. Localization of the genotypes. Eleven repeated genotypes, which were observed in four or more isolates, are represented with colored squares
on the map of the endemic areas of Alpes-Maritimes and Provence. The two endemic areas are separated by a blue line. The remaining genotypes are
represented by light brown squares. The area in the black rectangle is shown in further detail in Fig 3B. B. Detailed localization of isolates in the Alpes-
Maritimes endemic area and more precisely the surrounding region of Nice. Isolates were localized at the city level. The black line represents the delimitation
of Nice.
doi:10.1371/journal.pntd.0004303.g003
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isolate (1996) at only one marker (LIST7021). Re-infection was suspected for this patient; however,
further studies are warranted to confirm whether only one allelic change can lead to the suspicion
of a re-infection or reflects the evolution of the isolate over time. Patient 86 (HIV+) presented five
different episodes of VL due to active chronic VL [20]. Isolates from the second (2000), third
(2001) and last episode (2003) presented with the sameMLMT profile compared with the isolate
from the initial infection (1997). However, the MLMT profile of the fourth episode (2002) isolate
varied at 11 loci; only Rossi2 remained the same. Re-infection and relapse were suspected for this
patient. Each isolate of these multiple episodes was characterized zymodemeMON-1.
Association between genotype and clinical manifestation
Genetic differentiation among the various populations was tested using FSTAT Version
2.9.3.2.
In France, at the end of the 1990s and early 2000s, the repellent collar had been widely use
to protect dogs from parasitic transmission [21,22]. To determine whether this had an impact
on genetic differentiation, we compared the isolates before and after the introduction of repel-
lent collar in the AM and P endemic areas. To minimize the temporal effect on genetic variabil-
ity and determine whether the repellent collar led to a bottleneck effect, the samples collected
between 1996 and 2004 were excluded (Table 5). No differentiation was found in both endemic
areas, thereby suggesting no bottleneck effect due to repellent collar use.
Fig 4. Temporal distribution of the 11 genotypes represented by more than four isolates.
doi:10.1371/journal.pntd.0004303.g004
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Nine isolates from asymptomatic carriers were compared with 11 isolates from HIV patients
collected between 1994 and 1998 in the same restricted endemic area. To avoid bias, we
selected isolates collected two years before and after the date of the collection of the asymptom-
atic carrier isolates (1996). Unlike the findings reported by Hide et al., no genetic differentia-
tion was observed between isolates from asymptomatic carriers and those derived from HIV
+ patients (Table 5) [9]. However, additional isolates from asymptomatic carriers are required
to strengthen these findings. A genetic differentiation was observed between isolates from HIV
+ and VL adult patients in AM (Table 5).
Clustering analysis
Bayesian model-based analysis of the 270 isolates using STRUCTURE (with calculation of ΔK)
indicated two distinct genetic populations (Fig 5A). Population A consisted of 148 samples: 73
from P, 61 from AM, seven from CO and seven from CE. This population consisted of zymo-
demes MON-1 and nine isolates with zymodemes other than MON-1. Population B consisted
of 109 isolates: 104 from AM, two from P, two from CO and one from CE. Isolates from Popu-
lation B were all characterized zymodeme MON-1. Among the Populations A and B, 13 isolates
had mixed genotypes (11 isolates corresponding to seven genotypes and two isolates corre-
sponding to two genotypes in Populations A and B, respectively). The isolates with mixed
genotypes shared allele characteristics of each population. All isolates with mixed genotypes
were collected in the AM endemic area and were characterized zymodeme MON-1. Thus, Pop-
ulation A is a mixed population with almost an equivalent number of isolates from AM and P
corresponding to MON-1 and all non-MON-1 isolates. The estimated gene flow between iso-
lates from AM and P within Population A (Nm value) was 8.38. Population A also displayed a
marked proportion of isolates from HIV+ patients (44.7%) compared with Population B
(21.6%) (p<0.05). The two populations A and B defined by STRUCTURE were significantly
different as shown by the Fst value 0.503 and p-value equal to 0.05. The estimated gene flow
between the populations (Nm value) was 0.25, thereby indicating very few exchanges between
those two populations.
The STRUCTURE analysis of Population A separately from Population B, excluding
admixed isolates (13 isolates), revealed a delta K graph with two peaks at K = 4 and K = 6 (Fig
5B). The main difference between K = 4 and K = 6 was that sub-population A1’ at K = 4 was
Table 5. Differentiation measures (Fst) and testing (p-value) between different Leishmania infantum isolates according to the use of collar repel-
lent and clinical manifestations.
Subsamples Number of isolates Fst p-value
Effect of collar repellent. Comparison of isolates from 1978 to 1995 and 2005 to 2011 (years 1996–2004 excluded)
P endemic area 11 / 12 0.0412 0.15
AM endemic area 87 / 40  0 0.95
Comparison of clinical manifestations. Other means VL, CL, MCL
AM AC vs other 1991–2001 9 / 172 0.0763 0.10000
AM AC vs HIV isolated from 1994 to 1998 in the same endemic area 11 / 9 0.0830 0.10000
HIV + vs HIV - 95 / 150 0.0683 0.05000
HIV + vs VL adult 95 / 72 0.0857 0.05000
HIV + vs CanL CatL 95 / 21 0.0167 0.50000
P HIV + vs VL adult 40 / 11 0.0020 0.80000
AM HIV + vs VL adult 52 / 50 0.1510 0.05000
IVL vs CanL CatL 58 / 21 -0.0013 0.90000
VL vs IVL 70 / 57 0.0003 0.30000
doi:10.1371/journal.pntd.0004303.t005
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Fig 5. Estimated population structure for L. infantum from Southeastern France assessed using STRUCTURE software based on the analysis of
the 270 L. infantumDNA samples at 12 microsatellite markers. A: The plots show the estimated membership coefficient (Q) of each isolates. Each
isolate is represented by a single vertical line divided into K colors, in which K is the number of populations assumed. Each color represents one population,
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split into three populations at K = 6: sub-population A2 (four isolates from sub-population
A1’), A3 (16 isolates from sub-population A1’) and A4 (15 isolates from sub-population A1’).
Whether at K = 4 or K = 6, the sub-population defined contained isolates from the AM and P
endemic areas and from HIV+ patients. The non-MON-1 isolates were grouped into sub-pop-
ulation A1’ and A3’ with K = 4 and into sub-population A2, A4 and A6 with K = 6. No cluster
based on clinical data, geographic area or zymodeme profile was found within the defined sub-
populations. Some isolates displayed mixed genotypes within the A sub-populations. At K = 4
and K = 6, 26 and 44 isolates had mixed genotypes, respectively. At K = 6, isolates with mixed
genotypes came from P (n = 33; 75%), AM (n = 8; 18.2%) and CE (n = 3; 6.8%).
When excluding mixed genotypes, the sub-populations A1, A2, A3, A4, A5 and A6 as well
as A1’, A2’, A3’ and A4’ were significantly different, as shown by the significant Fst values rang-
ing from 0.249 to 0.833 and from 0.322 to 0.813 for K = 4 and K = 6, respectively (Table 6). At
K = 4, the highest Nm value was obtained between sub-population A1’ and sub-population A3’
(0.53), whereas at K = 6, the highest Nm value was 0.75 between sub-population A2 and sub-
population A6, thereby indicating only limited genotype flow between these sub-populations
(Table 6).
Two main sub-populations were defined using STRUCTURE for Population B: sub-popula-
tion B1 and sub-population B2. No mixed genotypes were present. Sub-population B1 con-
sisted of 48 isolates from AM, two from P and one from CO. Sub-population B2 consisted of
56 isolates from AM, one from CO and one from CE. These two sub-populations were geneti-
cally different as evidenced by the Fst value (0.537 and p-value = 0.05). Few exchanges occurred
between these two sub-populations (Nm = 0.22 was obtained between sub-population B1 and
sub-population B2).
Sub-populations A3’ (sub-population A K = 4) and A6 (sub-population A K = 6) displayed
the highest number of alleles per population (Table 7). The expected heterozygosity (He), a
measure of genetic diversity, was higher in the A sub-populations with non-MON-1 isolates
compared with the A sub-populations with only MON-1 isolates (Table 7). All A sub-popula-
tions displayed a high inbreeding coefficient (FIS) (> 0.7), whereas the sub-population B2 dis-
played a low inbreeding coefficient (0.343) (Table 7).
The NJ tree presented in Fig 6 provides a graphic representation of the data. The bootstrap
values based on the re-sampling of loci were low and therefore not included in the NJ tree (Fig
6). This was due to the presence of admixed genotypes and the high number of shared alleles
and the length of the colored segment shows the estimated proportion of isolates membership in that population. The derived graph for delta K shows K = 2,
thereby indicating the presence of two populations in the investigated sample set.B: Isolates of the sub-populations A and B with delta K values for each sub-
population. Two close values were observed for K in sub-population A: K = 4 and K = 6. For sub-population B, K = 2.
doi:10.1371/journal.pntd.0004303.g005
Table 6. Differentiation measures, migration rate and statistical significance between different Leishmania infantum isolates according to sub-
populations defined using STRUCTURE. In sub populations A, the isolates with mixed genotypes have been excluded (26 and 44 isolates for K = 4 and
K = 6, respectively). Only the highest and lowest Fst values are represented in this table.
Sub populations Number of Isolates Fst p-value Nm
Sub Pop A Pop A2’ vs A4’ 26 / 30 0.813 0.008 0.06
K = 4 Pop A1’ vs A3’ 52 / 14 0.322 0.008 0.53
Sub Pop A Pop A3 vs A5 16 / 26 0.833 0.003 0.05
K = 6 Pop A2 vs A6 7 / 13 0.249 0.003 0.75
Sub Pop B
K = 2 Pop B1 vs B2 51 / 58 0.537 0.050 0.22
Fst: degree of genetic differentiation, Nm: migration rates, p-value: statistical signiﬁcance.
doi:10.1371/journal.pntd.0004303.t006
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even if the allelic frequencies are different between the populations and sub-populations. Two
main clusters were found to correspond to the two populations obtained using STRUCTURE
at K = 2. Population B formed a separate cluster from Population A. The two sub-clusters
defined using STRUCTURE for Populations B1 and B2 are shown on the NJ tree. However, for
Population A, the clusters defined by the NJ tree did not perfectly correlate with the A sub-pop-
ulations defined using STRUCTURE for neither K = 4 nor K = 6. The sub-populations A1, A2
and A3 (A1: four genotypes from AM and seven genotypes from P; A2: one genotype from
AM, one from CO and three from P; and A3: eight genotypes from AM, two from P and one
from CO) are dispersed throughout the NJ tree. Within Population A, the isolates from AM
and P are dispersed throughout the cluster with no correlation with endemic area, clinical form
or host background. The mixed genotypes were present between the two main clusters of Pop-
ulations A and B as well as within the cluster of A sub-populations. Some non-MON-1 isolates
grouped together as a paraphyletic group in the sub-population A6, while the others were dis-
persed among the MON-1 isolates and are present at the end of the branches. As previously
described, the MON-108 isolate is closely related to the MON-1 isolates [23–25]. Regarding
the nine isolates from AC, two (genotype 21) were present in sub-population A5, whereas
seven (genotype 43) belonged to sub-population B1 and grouped with isolates from infant VL
and HIV + VL patients. None of the isolates from AC has a mixed genotype. Samples isolated
from CanL grouped together with human isolates, and no correlation was found between host
and MLMT profile.
Discussion
Leishmaniasis due to L. infantum is endemic in Southern France. In this study, we used
MLMT, a molecular tool useful for population genetic studies, to analyze an extensive set of
isolates from four endemic areas in Southern France (AM, P, CE and CO). To the best of our
knowledge, this study is the first to investigate a large number of L. infantum isolates from dif-
ferent endemic areas in Southern France. We also focused on the AM and P endemic areas
over an extended period of time. A greater number of samples came from AM than P
(AM = 178 versus P = 75) because AM is the most active foci in France with the greatest num-
ber of leishmaniasis cases per year [2]. The study period was also longer for the AM area than
Table 7. Descriptive statistics per population.
Name of the sub population n Na He Ho FIS
Sub Pop A Pop A1’ 52 3.500 0.380 0.066 0.830
K = 4 Pop A2’ 26 1.500 0.052 0.013 0.763
Pop A3’ 14 5.417 0.695 0.048 0.936
Pop A4’ 30 2.000 0.161 0.014 0.917
Sub Pop A Pop A1 27 1.917 0.149 0.012 0.920
K = 6 Pop A2 7 2.417 0.395 0.071 0.843
Pop A3 16 1.917 0.169 0.016 0.913
Pop A4 15 1.917 0.184 0.006 0.972
Pop A5 26 1.500 0.052 0.013 0.763
Pop A6 13 5.000 0.680 0.051 0.931
Sub Pop B Pop B1 51 1.500 0.080 0.011 0.860
K = 2 Pop B2 58 1.917 0.067 0.0445 0.34337
In sub populations A, the isolates with mixed genotypes have been excluded (26 and 44 isolates for K = 4 and K = 6, respectively). n: number of isolates
per population; Na: number of alleles; Ho: observed heterozygosity; He: expected heterozygosity; FIS: inbreeding coefﬁcient.
doi:10.1371/journal.pntd.0004303.t007
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for the P endemic area (AM: 1978–2011; P: 1993–2009). This aspect may generate a sampling
bias, although no significant genetic differentiation was found when comparing isolates from
AM and P during the same time period. Although MON-1 is the most prevalent zymodeme,
other zymodemes also circulate in the south of France [7]. Microsatellite characterization of L.
infantum isolates revealed a total of 121 different genotypes. Overall, 91 unique genotypes and
30 repeated genotypes were found. A greater number of repeated genotypes were observed in
AM compared with P for the same period, thereby suggesting variations in the transmission
cycle between the two areas such as outbreak, vector diversity or density, or host density.
In the AM endemic area, the isolates belonged to two main populations as defined by
STRUCTURE: Population A and Population B. Within Population A, gene flow occurred
between the AM and P endemic areas. The spread of isolates seems to be from AM to P, as
indicated by the results of genotype 21, which was found 15 years later in P.
Substantial genetic diversity was found to be comparable to other endemic areas, even
within zymodeme MON-1, thereby confirming previous analyses assessed by other markers
[26]. As genetic differentiation depends on the area, our findings suggest strong epidemiologi-
cal structuring. This is in agreement with the known mechanism of Leishmania transmission
and spread in micro-foci and the entomologic data that have demonstrated limited sandfly dis-
persion [27–31]. Indeed, considering the behavior of the phlebotomine sandfly, it seems less
likely that the spread of isolates from AM to P is due to sandfly movement [32]. Unfortunately,
due to the small sample size of the phlebotomine sandfly isolates, we cannot investigate the
transmission between sandflies, humans and canine hosts in further detail. We suspect that
people traveling with their infected dogs between the endemic areas plays a possible role in the
etiology of these exchanges. This has been already described for the emergence of L. infantum
in South America probably via Conquistadores infected dogs from Portugal [33]. More
recently, an intercontinental transportation from France to French Guiana was also reported
due to the probable importation of L. infantum from an infected dog [34]. Notably, some
repeated genotypes in the AM endemic area are well settled and continue to spread through
the area over time. Indeed, some repeated genotypes were detected during a limited period,
ranging from 6 to 15 years, and are no longer detected (genotypes 36, 43, 46, 53, 68 and 77).
However, other genotypes were still detected in 2011 (genotypes 34, 55 and 57) and one geno-
type spread to P endemic area (genotype 21). The mixed genotypes between Population A and
Population B were isolated in the AM endemic area, whereas in the A sub-populations, 75% of
the mixed genotypes came from the P endemic area. We also observed a predominance of iso-
lates from HIV+ patients in Population A (44.7%) compared with Population B (21.6%), which
may indicate a variation in virulence. Indeed, these isolates from HIV+ patients may produce
leishmaniasis in immunocompromised patients, whereas affected immunocompetent patients
may develop only an asymptomatic infection [35]. This hypothesis is in agreement with the
distribution of isolates from AC in both Population A and Population B. These isolates
belonged to the genotypes 21 (2 AC) and 43 (7 AC), with samples from HIV+ VL, IVL, VL and
CanL cases and samples from infant VL and HIV+ VL patients, respectively. The comparison
of isolates from AC and those from HIV+ patients isolated during the same period and within
Fig 6. Unrooted neighbor-joining tree inferred from genetic distances derived from the proportion of alleles shared among the 270 isolates of L.
infantum based on 12microsatellite markers. The two populations defined using STRUCTURE are highlighted. The blue stars correspond to the non-
MON-1 strains. At the end of each branche of the network, the first three characters correspond to the arbitrarily assigned number for each genotype, the
following two characters (AM, P, Ce, Co) correspond to the endemic area of sample collection, and then the last two characters correspond to the number of
isolates with the given genotype. The orange rectangles represent the isolates with mixed genotypes. The sub populations are represented with colored
ovals at K = 6 for A sub-populations and K = 2 for B sub-populations. The isolates with no color are those with mixed genotypes within A sub-populations at
K = 6. MEGA 4 software was used to visualize the neighbor-joining tree.
doi:10.1371/journal.pntd.0004303.g006
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the same restricted endemic area revealed no genetic differentiation between these populations.
This finding contrasts with previous data reported by Hide et al. [9] and as suspected, does not
reflect a difference in virulence. However, further isolates from asymptomatic carriers must be
assessed to confirm our hypotheses. This is critical in the endemic areas of Southern France (as
well as all endemic foci of leishmaniasis), where the isolates responsible for leishmaniasis repre-
sent only the tip of the iceberg [36]. Indeed, depending on the test used to detect asymptomatic
carriage, prevalence varies from 30% to 46.8% in the AM endemic area [36]. Although our
study provides important insight into leishmaniasis epidemiology in AM and P, our panel rep-
resents only a small proportion of the L. infantum population circulating in Southern France as
samples from asymptomatic carriers, dogs and sandflies are underrepresented.
Microsatellite analyses may be useful to estimate relapse and re-infection rates, which is
important to evaluate anti-Leishmania drug efficacy and transmission dynamics, respectively.
This aspect is particularly important for the follow-up of patient treatment. MLMT may also
be a useful tool to differentiate between relapses from re-infection cases [11,25,26,35,37,38].
Moreover, Bourgeois et al. have described “active chronic visceral leishmaniasis” in patients
with several episodes of VL [20]. In this particular form of the disease, identifying the MLMT
profile of each isolate responsible of each episode of VL could be useful to monitor and opti-
mize treatment regimes. In our study, we detected probable treatment failure in HIV+ and
non-HIV patients, as the MLMT profiles were indistinguishable from one episode to another.
Certain patients likely experienced re-infection, as isolates from two different episodes of leish-
maniasis in same patient displayed different MLMT profiles. However, we cannot exclude the
possibility of a mixed infection with differential strain isolation depending on the time of sam-
pling. Due to the small number of patients with isolates from several biological samples at dif-
ferent times, the rate of relapse and re-infection needs to be confirmed on a larger sample set.
Thus, the results on relapse and re-infection should be interpreted with caution. Further inves-
tigations are required to assess these hypotheses in further detail.
The high ratio of repeated genotypes in HIV patients (81.6%) compared with the remaining
population (41%) may be due to an outbreak amongst this fragile human population. Out-
breaks have already been reported among intravenous drug users, a population also frequently
affected by HIV infection [39,40]. Nevertheless, we have no information concerning this aspect
of the case population in our study.
Faucher et al. have highlighted the heterogeneity of environments associated with VL trans-
mission in Southeastern France [5]. The authors showed two distinct foci strongly associated
with specific environments. One focus, corresponding to the AM endemic area, was character-
ized by scattered habitation and mixed forest in the foothills. In contrast, the other focus in the
P endemic area was centered in urban areas of Marseille. These environmental differences cor-
relate with the strong genetic differentiation we found between the Leishmania populations
from AM and P. Indeed, the ecosystem influences the transmission cycle and thus the popula-
tion dynamics of parasites. Moreover, in the P endemic area, Toscana virus, which is responsi-
ble for summer meningitis, and L. infantum share the same vector, Phlebotomus perniciosus. A
recent study has described dogs co-infected by these two organisms [41]. Although cases of co-
infection in humans or vectors have not been reported, we suspect that is also possible. This
phenomenon of co-infection may have an impact on Leishmania transmission and should be
addressed in future studies to understand whether this may also influence parasite evolution.
Other wild reservoirs of L. infantum have been demonstrated in Europe such as fox, rats
and hare [42]. These wild reservoirs are able to transmit L. infantum to sandflies. However, the
isolates from wild reservoirs have indistinguishable genotypes from those derived from domes-
tic dogs and humans [26,43]. No isolates from wild animals were included in our study. The
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only uncommon host included in our study was a cat, and the isolate from this animal shared
the genotype 55 with isolates from dog, IVL, HIV+ VL and VL samples.
In some studies, the isolates with a zymodeme other than MON-1 grouped together either
via neighbor joining tree or STRUCTURE analysis [25,26]. We did not find such correlations
with our data which is probably due to the high number of strains with mixed genotypes.
Indeed the nine non-MON-1 isolates did not group into a separate population but rather clus-
tered into Population A with a majority of the MON-1 isolates. In the NJ tree, some non-
MON-1 isolates appeared as a paraphyletic group, while others were either isolated or dis-
persed among other zymodemes [23–25]. The zymodeme MON-108 (genotype 92) isolate
appeared very close to MON-1 isolates with the genotype 37 [23–25].
In our study, no correlation was found between MLMT profile, clinical expression of the
disease, immune status and host. Finally, MLMT is more discriminant and thus more appro-
priate than MLEE to evaluate epidemiological changes among parasite population in Southern
France. MLMT data provided a better understanding of gene flow between L. infantum popula-
tions within the Southeastern France endemic area.
Supporting Information
S1 Table. Designation, characteristics and MLMT profiles of the Leishmania infantum iso-
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maniasis; MCL–Muco-cutaneous leishmaniasis; RVL—New episode of leishmaniasis in
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PHLE: isolate from phlebotomine sandfly; UK–Unknown. n. d. = not defined.
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